- Thursday, 26th September | Conference Day One
- Friday, 27th September | Conference Day Two
Breakfast, Registration & Networking begins at 8am ET
Chairs Opening Remarks & Setting the Scene
Chair to be Announced
9:10am ET
Keynote Panel Discussion: Healing by Software
We’re back and better than ever. Prepare to embark on a journey led by a diverse set of DTxperts from all corners of the field. Join us as we highlight success stories, identify impactful disease areas, and get to the bottom of clinician adoption.
Mette Dhyrberg, Founder & CEO, Mymee
John Cambell, Head of Decentralized Clinical Trials, Walgreens
Neil Hattangadi, Chief Executive Officer, Cortica
Niren Kocchar, Associate Vice President, Product Management – Consumer Strategy, Design and Transformation, Humana
9:50am ET
Fireside Chat: How Digital Therapeutics Saved My Life: Being Patient
At the heart of what we do, it always comes back to the patients. It’s important we don’t forget that. Prepare to be captivated by real-life narratives of the patient’s perspective. Guided by personal success stories, this session sheds light on the real life impact DTx has on people.
Benjamin Alouf, Chief Medical Officer, Digital Therapeutics Alliance
Patient of DTx
Chairs Opening Remarks & Setting the Scene
Chair to be Announced
9:10am ET
Presentation: Navigating the Digital Health Landscape in Pharma: Trends, Challenges, and Evidence-Based Progress
This presentation, led by an industry expert, will kick off the day by establishing the foundation for evidence-based digital health in pharma. It will delve into the ongoing trends and challenges encountered by the pharmaceutical sector when adopting digital health technologies, and offer insights into how we can utilize evidence to progress the industry.
Celine Marquez, Global Medical Director, Digital Health Technologies, Genentech
9:50am ET
Panel Discussion: Integrating Digital Health Innovation with Corporate Strategies and Operating Models
Our keynote panel explores the expansive realm of digital health, emphasizing the need for comprehensive assessments of revenue, cost, and success factors. Join industry leaders as they share insights and strategies for navigating the adoption of these technologies.
Moderator: Celine Marquez, Global Medical Director, Digital Health Technologies, Genentech
Meri Kay Scott, Associate VP, Digital Health R&D – Clinical Operations, Eli Lilly
Davide Ricci, US Vice President, SaMD, Novo Nordisk
Chairs Opening Remarks & Setting the Scene
Michael Levy, Chief Executive Officer, Digital Health Institute for Transformation
9:10am
Keynote Panel Discussion: The Sweet Spot | Hybrid Care
As virtual-first care has become more integrated into care, the popular opinion is that hybrid care is the most effective way which virtual-first care may embed itself in. This panel will hone in on how we can optimize our approach for combining traditional and virtual healthcare for efficient and improved health outcomes.
Gaurav Shivhare, Head of Product, Virtual Care, CVS Health
Sarah Schneck, Executive Director of ChristianaCare Centre for Virtual Health, ChristianaCare
Christopher LaCoe, Vice President, Virtual Health, Penn State Health
Navi Mudahar, Director, Virtual Care, Blue Shield of California
Reena Bhargava, Medical Director of Digital Health, Telehealth, Virtual Care Health Care Delivery, Kaiser Permanente
Session to be Announced
Morning Refreshments & Networking in the Exhibition Hall
Plenary Keynote Panel: Welcome to The Digital Healthcare Revolution
Three crucial pillars of digital healthcare – Digital Therapeutics (DTx), Evidence-Based Digital Health in Pharma, and Virtual-First Care unite in Boston. We delve into the uncharted territories of the digital health landscape, exploring the future of our connected healthcare journey. Join us for the first-ever HealthTech ConX panel, we’re not just discussing the future; we’re shaping it…
- Exploration of upcoming trends shaping the trajectory of our connected healthcare journey
- Strategies and initiatives aimed at fostering interoperability for enhanced collaboration and seamless data sharing among various digital health platforms and stakeholders
- Emphasis on prioritizing cybersecurity measures to safeguard patient privacy and data integrity amidst the expanding digital healthcare landscape
- Anticipation of groundbreaking advancements in diagnostics and treatment modalities through the continued integration and evolution of AI and machine learning technologies
- Focus on collaborative approaches and innovative solutions to bolster patient engagement, ensuring active involvement and adherence to digital health interventions for improved healthcare outcomes
Robert Gabbay, Chief Medical & Scientific Officer, American Diabetes Association
Tarun Kapoor, Chief Digital Transformation Officer, Virtua
Alex Condoleon, Chief Medical Affairs Officer of Global Medical Engagements & Impact, Pfizer
Cole Zanetti, Chief Informatics Health Officer, U.S Department of Veteran Affairs
Plenary Keynote Panel: The Payer’s Speak: Everything You Need to Know About Digital Health Reimbursement
The question on everyone’s mind. Payers will come together to take the stage and run through their do’s and dont’s when it comes to reimbursement. Learn how you can stand out amongst the crowd and be the next healthcare revelation…
- What digital technologies are proving to be most successful for payers, and which companies are they more inclined to collaborate with?
- How can both sides of the coin, payer and innovator, better facilitate discussion and negotiations regarding reimbursement?
- What are your options when it comes to reimbursement and how do you pick the right path?
- What are payers looking at when evaluating the effectiveness of digital tools for reimbursement?
Timothy Law, Chief Medical Officer, Highmark
Chris Jagmin, Vice President, Deputy Chief Medical Officer, Aetna
Kara Ellinger, Staff VP, Virtual Care, Anthem
Aditi Malick, Chief Medical Officer, Medicaid & CHIP, Acting Director, CMS Office of Minority Health, Medicare & Medicaid
Lunch & Networking in the Exhibition Hall
Panel Discussion: We’re Stronger Together: Digital Therapeutics and Pharma as One
A love hate relationship seems to stick with pharma and DTx, depending on who you’re talking to. Here we explore what’s been working for a lot of DTx / Pharma partners and analyze how to build and maintain the camaraderie between the two.
John Drakenberg, Founder & CEO, Alex Therapeutics
Jessica Shull, Director of Digital Therapeutics, Vicore Pharma
Ciara Clancy, Founder & CEO, Beats Medical
Classified Pharma Partner TBA On-Stage
2:55pm ET
Panel Discussion: Consolidating DTx: Mergers and Acquisitions. This is How We Did it
In a landscape beaming with innovation, mergers and acquisitions have become the strategic linchpins propelling DTx to new heights. Dive into the heart of the action as industry insiders spill the secrets behind the surge in DTx consolidations. Learn why organizations are coming together, exploring the critical features that define alignment before the merger dance begins.
Chris Wasden, Chief Strategy Officer, Twill
Rick Anderson, President, Dario Health
Simon Levy, CEO & Founder, Mahana Therapeutics
Speaker TBC, Cara Care
Panel Discussion: Innovation Meets Regulation: The Evolving Digital Health Landscape in Pharma
As the regulatory landscape for digital health in pharma undergoes rapid transformation, this panel will shed light on the latest regulatory developments and their implications. Participants will engage in a deep dive into the specific regulatory hurdles and compliance strategies essential for advancing evidence-based digital health solutions within the pharmaceutical sector.
Moderator: Amir Lahav, Strategic Advisor, Pharma & MedTech
Lori Roadcap, Senior Director, Global Regulatory Strategy and Policy for Precision Medicine, Diagnostics and Digital Health, Bristol Myers Squibb
Sarah Fairfield, Associate Director Regulatory Affairs, AbbVie
2:55pm ET
Case Study Presentation: Google’s Assessment of Wearables
In this presentation, Kapil Parakh, Senior Medical Lead at Google, presents a case study on Google’s evaluation of wearables, offering insights into their potential impact on healthcare. Through real-world examples and expertise, Parakh illustrates how Google assesses the efficacy and integration of wearable technology in medical contexts.
Kapil Parakh, Senior Medical Lead, Google
Panel Deep Dive: Virtual-First Care in Women’s Health
This panel delves deeply into the concept of virtual-first care within the realm of women’s health, exploring its implications, challenges, and potential benefits. Through expert insights and case studies, the panelists provide a comprehensive examination of how virtual care models are transforming and optimizing healthcare delivery specifically for women.
Tracy Dooley, Partner, Avestria Ventures
Erkeda DeRouen, Chief Medical Officer, Emme
2:55pm ET
Panel Discussion: All Populations Considered – How are We Ensuring Virtual-First Care is Designed with All Patient Populations in Mind
It is crucial to ensure virtual-first care is providing value across all populations of patients. This panel will focus on the continuing challenges for patients, and look at how we can improve virtual-first care delivery and be creative when thinking of providing the most valuable and accessible care and what strategies can be imp
Stacy Lloyd, Director of Digital Health & Operations, American Medical Association
Tifanie Sbriscia, Director, Wound & Ostomy Care – Telemedicine, VNA Health Group
Matthew Lomeli, Medical Director, Telehealth and Patient Service Centre, AltaMed Health Services
Joe Connolly, Co-founder & CEO, Visana Health
Bonnie Feldman, Co-founder and Chief Patient Officer, Rheumissison
Afternoon Refreshments and Networking in the Exhibition Hall
Presentation: Looking Past the Therapy: How to Build a Personalized and Engaging DTx Program
Mark Guarraia, Vice President, Future User Experience Devices and Delivery Solutions, Novo Nordisk
4:35pm ET
Panel Discussion: Data Driven Decisions: Shaping the Evidence Standards in Digital Therapeutics
In a world where technology evolves at breakneck speed, explore how evidence standards in DTx can stay nimble and adaptable to emerging data sources, ensuring they remain at the forefront of technological advancements. Dive into the heart of data-driven decisions as we explore the pivotal role of evidence standards in digital therapeutics.
Shaheen Lakhan, Chief Medical Officer, Click Therapeutics
Jordan Silberman, Director of Clinical Analytics and Research, Office of Med Policy & Tech Assessment, Elevance Health
Panel Discussion: Generating and Assessing Clinical and Real-World Evidence for Digital Health Adoption in Pharma
In an era marked by rapid technological advancements and the proliferation of digital health solutions, the pharmaceutical industry is increasingly relying on evidence from clinical data and real-world data (RWD) to inform decision-making. This panel will delve into the critical considerations and best practices for assessing evidence when adopting digital health technologies in pharma, aiming to strike a balance between innovation and rigorous evaluation.
Moderator: Sarah Valentine, Partnerships Lead, Digital Medicine Society (DiMe)
Kelly Zou, Head of Medical Analytics, RWE, and HEOR, Viatris
Viviktha Ramesh, Clinical and Evidence Expert, Roche Information Solutions
Jay Trudeau, Senior Director, Patient-Focused Endpoints and Measurement, Eli Lilly
4:55pm ET
Panel Discussion: Strategies for Adopting Digital Health: Build, Buy, or Partner?
In today’s rapidly evolving healthcare landscape, pharmaceutical companies must explore various pathways to adopt digital health technologies effectively. This panel will delve into the approaches of building digital solutions in-house, acquiring them externally, or forming strategic partnerships to harness the potential of digital health in pharma.
Catherine Blanchette, Global Head of Digital Innovation & Partnerships, Sanofi
Ofer Waks, Director, Digital Strategy and Innovation, Pfizer
Norah Xiao, Director Digital Health Partnership, AstraZeneca
Yao Zhang, Senior Director of External Innovation in Interventional Oncology, Johnson & Johnson
Presentation Spotlight: Virtual Inpatient Monitoring
Join Cindy Welsh, Vice President of System TeleAcute and Respiratory Care at Advocate Health MidWest, as she shines a spotlight on Virtual Inpatient Monitoring. Discover the transformative potential of this cutting-edge approach to patient care within the hospital setting, revolutionizing how healthcare is delivered and monitored in real-time.
Cindy Welsh, Vice President, System TeleAcute and Respiratory Care – MidWest, Advocate Health
4:55pm ET
Panel Discussion to be Announced
HealthTech ConX Drinks Reception & Networking
Close of HealthTech ConX Day One
Breakfast, Registration & Networking begins at 8am ET
Chair’s Opening Remarks and HealthTech ConX Day One Recap
HealthTech ConX Shark Tank Pitches
Get ready for an exhilarating session as we bring you the much-anticipated HealthTech ConX Shark Tank! This is an opportunity to witness ground-breaking revolutionizing the digital healthcare landscape
Each innovative start-up will have a spotlight moment, with a dynamic 10-minute pitch that could change the game for maternal care. Picture this: a whirlwind of ideas, passion, and vision to transform the digital health space! After each pitch, hear from the panel of leading investors providing invaluable feedback in a lightning-fast 5-minute exchange!
Panel of Investors:
Erika Seth Davies, Chief Executive Officer, Rhia Ventures
Cris De Luca, Partner, Digital/AI Investments, Sanofi Ventures
Adam Kundzewicz, Executive Director, Venture Fund, Boehringer Ingelheim
Miles Gerson, Executive Investment Director & Partner, Takeda Ventures
Sophie Park, Managing Director – G4A Investments & Partnerships, Bayer G4A
Start up competition will run from July 1st. Get in touch for more information
Plenary Keynote Panel: FDA Q&A: The Digital Health Center of Excellence
Gain an understanding of the key considerations the FDA weighs when evaluating and approving digital tools. Explore the FDA’s strategy for staying abreast of emerging technologies and novel treatment modalities, ensuring regulatory agility in a rapidly evolving field…
- An overview of the DHCoE’s recent work and plans for digital healthcare over the next year.
- What are the key considerations that the FDA takes into account when evaluating and approving digital tools?
- How does the FDA plan to keep pace with new emerging technologies and novel treatment modalities?
- What does the FDA need from other stakeholders in the industry to facilitate a smoother regulatory environment?
Speakers to be Announced
Morning Refreshments & Networking in the Exhibition Hall
Panel Discussion: Machines Have Minds: The Role of AI & Generative Learning in DTx
It’s clear that like everything else, healthcare is not going to escape AI, and that goes for DTx too! With the industry revolutionizing personalized patient care and crafting solutions with unprecedented precision, DTxperts must join the journey. We’ll navigate the ethical considerations of AI in healthcare, discussing responsible deployment and showcasing real-world success stories where AI-driven DTx has yielded remarkable patient outcomes…
Siva Nadarajah, President, JOGO Health
Anand Iyer, Chief Analytics Officer, Welldoc
Alexey Youssef, Co-Founder & CEO, Sky Therapeutics
Michael Kremliovsky, Senior Director, Medical Devices & eHealth, Science Fellow, Bayer
12:10pm ET
Closing Panel Discussion to be Announced
Keynote Panel Discussion: A Multi-Stakeholder Perspective on Building Patient-Centric Digital Health
At its core, our objective is to harness the transformative potential of digital health to elevate patient outcomes, so it is important to analyze if patient perspectives are considered at all levels of digital health technology development. This panel discussion will explore strategic insights into how the pharmaceutical industry can optimally embrace a patient-centric approach when implementing digital health solutions, collaborating with other stakeholder groups to ensure that patient perspectives and patient outcomes shape the future of healthcare technology.
Moderator: Viviktha Ramesh, Clinical and Evidence Expert, Roche Information Solutions
Jen Horonjeff, Co-Founder & CEO, Savvy Cooperative
Sarah Small, Associate Director, Patient Centricity, Moderna
Jennifer Joe, Global Medical Strategy & Population Health Director, AstraZeneca
12:10pm ET
Panel Discussion: Looking into the Future for Digital Health: Big Data Technologies and Artificial Intelligence
In an era of rapid technological advancement, innovation in digital health technology is reshaping the healthcare landscape. Join this engaging panel to gain insights into the cutting-edge applications of big data technologies and AI in healthcare and pharmaceuticals, and learn how these technologies are poised to revolutionize decision-making processes.
Moderator: Kelly Zou, Head of Medical Analytics, RWE, and HEOR, Viatris
Charmaine Demanuele, Executive Director, Head of Quantitative Sciences for Digital Sciences & Translational Imaging, Pfizer
Ramya Palacholla, Director, Digital Science, AstraZenecaB
Jessica Lipschitz, Associate Director, Digital Behavioral Health and Informatics Research Program, Brigham and Women’s Hospital
Fireside Chat: Three Stances on AI – An Assistant, A Replacement and a Harm
During this session three individuals will speak on their stance on AI’s role in care and virtual-first care. Each individual will present for 5 minutes. There will then be 20 minutes of questions from the moderator, and 10 minutes of audience Q&A. Finishing up with an audience vote.
Geoffrey Rutledge, Chief Medical Officer & Co-founder, HealthTap
Sheena Franklin, Founder & CEO, K’ept Health
11:55am ET
Panel Discussion: Innovative Routes & Partnerships in Virtual-First Care – Building Seamless and Sustainable Solutions Across Industries
Join us for the Closing Panel Discussion on “Innovative Routes & Partnerships in Virtual-First Care,” where experts will explore the integration of virtual care across industries. Discover how seamless collaborations are forging sustainable solutions, revolutionizing healthcare delivery in the virtual age
Rory Farrand, Vice President, Palliative and Advanced Care, National Hospice and Palliative Care Organization
Guillaume Cohen-Skalli, Co-founder & CEO, Paloma Health
Zach Hochstetler, Vice President of Coding & Payment, American Medical Association
Randy Forman, Chief Commercial Officer, Oshi Health
Chairs Closing Remarkers & Event Recap
Close of the HealthTech ConX Summit
Registeration Enquiries
Interested in attending! Head over to the registration page or reach out for group booking discounts.